Correlation of Mean Platelet Volume with D-dimer in Patients with COVID-2019

Authors

  • Agri Febria Sari Faculty of Medicine, Andalas University
  • Rikarni Rikarni Department of Clinical Pathology, Faculty of Medicine, Andalas University. Functional Medical Staff, M.Djamil Hospital, Padang, Indonesia
  • Desywar Desywar Department of Clinical Pathology, Faculty of Medicine, Andalas University. Functional Medical Staff, M.Djamil Hospital, Padang, Indonesia

DOI:

https://doi.org/10.24293/ijcpml.v29i1.2030

Keywords:

Mean platelet volume, D-dimer, COVID-19

Abstract

SARS-CoV-2 binds to ACE2 receptors and causes endothelial injury. Endothelial injury causes the release of tissue factors and triggers the activation of the coagulation cascade, which is characterized by an increase in D-dimer levels. The increase in D-dimer levels reflects the activation of coagulation and fibrinolysis. Endothelial injury leads to platelet adhesion and aggregation. Mean platelet volume is a low-cost, routinely performed parameter available in hematology analyzers at various health facilities. This study aimed to determine the correlation between MPV and D-dimer in COVID-19 patients. This study was an analytical study with a cross-sectional design conducted on 88 subjects aged 18-50 years from COVID-19 patients who were admitted at Dr. M. Djamil Central Hospital in May-September 2021. Mean platelet volume levels were measured using the impedance method and D-dimer levels using the ELISA method. Data were analyzed using the Pearson correlation test, significant if p<0.05. The mean age was 33.47 years, range of 18-50 years. Most of the subjects were female, 53 people (62.4%). The mean MPV level was 10.36 (0.87) fL. The mean D-dimer levels were 728.51 (500.99) ng/mL. Correlation analysis showed that mean platelet volume had a weak positive correlation with D-dimer (r=0.269, p=0.013). This study showed an increase in MPV and D-dimer levels in COVID-19 patients. There is a weak correlation between MPV and D-dimer in COVID-19 patients.

Downloads

Download data is not yet available.

Author Biographies

Agri Febria Sari, Faculty of Medicine, Andalas University

Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Universitas Andalas/Dr. M. Djamil Hospital, Padang

Rikarni Rikarni, Department of Clinical Pathology, Faculty of Medicine, Andalas University. Functional Medical Staff, M.Djamil Hospital, Padang, Indonesia

Department of Clinical Pathology, Faculty of Medicine, Andalas University. Functional Medical Staff, M.Djamil Hospital, Padang, Indonesia

Desywar Desywar, Department of Clinical Pathology, Faculty of Medicine, Andalas University. Functional Medical Staff, M.Djamil Hospital, Padang, Indonesia

Department of Clinical Pathology, Faculty of Medicine, Andalas University. Functional Medical Staff, M.Djamil Hospital, Padang, Indonesia

References

Perhimpunan Dokter Paru Indonesia (PDPI), Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI), Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (PAPDI), Perhimpunan Dokter Anestesiologi dan Terapi Intensif Indonesia (PERDATIN), Ikatan Dokter Anak Indonesia (IDAI). Tatalaksana COVID-19 dengan komorbid atau komplikasi dalam pedoman tatalaksana COVID-19. Ed 3., 2020; 66.

World Health Organization. Clinical management of COVID-19. Interim Guidance, 2020; 1-62.

World Health Organization. WHO Coronavirus (COVID-19) Dashboard, 28 September 2021; 1.

Kementerian Kesehatan Republik Indonesia. Dashboard data kasus COVID-19 di Indonesia. 2021; 1.

Huang C, Wang Y, Li X, Ren L, Zhao J, et al. Clinical features of patients infected with 2019 novel Coronavirus in Wuhan, China. Lancet, 2020; 395(10223): 497-506.

Miesbach W, Makris M. COVID-19: Coagulopathy, risk of thrombosis, and the rationale for anticoagulation. Clinical and Applied Thrombosis/Hemostasis, 2020; 26: 1-7.

Yang X, Yu Y, Xu J. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir Med, 2020; 8(5): 475-81.

Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, et al. High risk of thrombosis in patients in severe SARS-CoV-2 infection: A multicenter prospective cohort study. Intensive Care Med, 2020; 46(6): 1089-1098.

Llitjos JF, Leclerc M, Chochois C, Monsallier JM, Ramakers M, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost, 2020; 00: 1–4.

Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thrombosis Research, 2020; 194: 101–115.

Barnes GD, Burnett A, Allen A, Blumenstein M, Clark NP, et al. Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: Interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis, 2020; 50(1): 72-81.

Mucha SR, Dugar S, McCrae K, Joseph DE, Bartholomew J, et al. Coagulopathy in COVID-19: Manifestations and management. Cleve Clin J Med, 2020; 87(8): 461-468.

Riley RS, Gilbert AR, Dalton JB. Widely used types and clinical applications of D-dimer assay. Lab Med, 2016; 47: 90–102.

Linkins LA, Lapner ST. Review of D-dimer testing: Good, bad, and ugly. Int J Lab Hematol, 2017; 39 (1): 98–103.

Thachil J, Lippi G, Favaloro EJ. D-dimer testing: Laboratory aspects and current issues. Methods Mol Biol, 2017; 1646: 91–104.

Favresse J, Lippi G, Roy PM, Chatelain B, Jacqmin H, et al. D-dimer: Preanalytical, analytical, post-analytical variables, and clinical applications. Critical Reviews in Clinical Laboratory Sciences, 2018; 55(8): 548–77.

Perhimpunan Dokter Paru Indonesia (PDPI), Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI), Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (PAPDI), Perhimpunan Dokter Anestesiologi dan Terapi Intensif Indonesia (PERDATIN), Ikatan Dokter Anak Indonesia (IDAI). Definisi kasus dan derajat penyakit dalam

pedoman tatalaksana COVID-19. Ed 3., 2020; 3-7.

Naymagon L, Zubizarreta N, Feld J, van Gerwen M, Alsen M, et al. Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19. Thromb Res, 2020; 196: 99-105.

Zhang L, Yan X, Fan Q, Liu H, Liu X, et al. D-dimer levels on admission to predict in-hospital mortality in patients with COVID-19. J Thromb Haemost, 2020; 18: 1324– 29.

Soeliauwan S, Muhadi D, Mutmainnah. Platelet indices for predicting liver fibrosis in patients with chronic hepatitis B infection. Indonesian Journal of Clinical Pathology and Medical Laboratory, 2018; 25(1): 35-7.

Cail Q, Huang D, Yu H, Zhu Z, Xia Z, et al. COVID-19: Abnormal liver function tests. Journal of Hepatology, 2020; 73: 566–74.

Taha M, Sano D, Hanoudi S, Esber Z, Elahi M, et al. Platelets and renal failure in the SARS-CoV-2 syndrome. Platelets, 2020; 32(1): 130-137.

Nugraha IKA, Atmaja KS, Suryana K, Putra WWS. The relation between mean platelet volume and platelet distribution width to COVID-19 severity. Int J Adv Med, 2021; 8(8): 1026-1031.

Bauer P, Brugger J, König F, Posch M. An international comparison of age and sex dependency of COVID-19

deaths in 2020: A descriptive analysis. Scientifc Reports Nature Portfolio, 2021; 11: 19143.

Li Q, Guan X, Wu P, Wang X, Zhou L, et al. Early transmission dynamics in Wuhan, China, of novel Coronavirus-infected pneumonia. N Engl J Med, 2020; 382: 1199–207.

Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, et al. Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China. Allergy, 2020 75: 1730-1741.

Schurz H, Salie M, Tromp G, Hoal EG, Kinnear CJ, Moller M. The X chromosome and sex-specific effects in infectious disease susceptibility. Human Genomics, 2019; 13(1): 2.

Ahmed SB, Dumanski SM. Sex, gender and COVID-19: A call to action. Canadian Journal of Public Health, 2020; 111: 980–983.

Jin JM, Bai P, He W, Wu F, Liu XF, Han DM, et al. Gender differences in patients with COVID-19: Focus on severity and mortality. Front Public Health, 2020; 8: 152.

Güçlü E, KocayiÄŸit H, Okan HD, Erkorkmaz U, Yürümez Y, et al. Effect of COVID-19 on platelet count and its indices. REV ASSOC MED BRAS, 2020; 66(8): 1122-1127.

Gumus H, Demir A, Yükkaldı ran A. Is mean platelet volume a predictive marker for the diagnosis of COVID-19 in children?. Int J Clin Pract, 2020; 00: e13892.

Afsar N, Afroze IA, Tahniath H, Abid Z. Role of mean platelet volume as an adjunct in evaluation of acute inflammation. Ann Pathol Lab Med, 2017; 4(4): 466-9.

Chen Y, Zhong H, Zhao Y, Luo X, Gao W. Role of platelet biomarkers in inflammatory response. Biomark Res, 2020; 8(1): 28.

Jeske WP. Platelet production, structure, and function. In: Rodak's hematology clinical principles and applications. 6th Ed., Elsevier Saunders, United State of America, 2020; 136-53.

Al Mutair A, Alhumaid S, Alhuqbani WN, Zaidi ARZ, Alkoraisi S, et al. Clinical, epidemiological, and laboratory characteristics of mild-to-moderate COVID-19 patients in Saudi Arabia: An observational cohort study. Eur J Med Res, 2020; 25: 61.

Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, et al. COVID-19 in critically ill patients in the Seattle Region”case series. N Engl J Med, 2020; 382(21): 2012–22.

Taus F, Salvagno G, Cane S, Fava C, Mazzaferri F, et al. Platelets promote thromboinflammation in SARSCoV-2 pneumonia. Arterioscler Thromb Vasc Biol, 2020; 40(12): 2975- 89.

Hunt BJ, Levi M. The source of elevated plasma D-dimer levels in COVID-19 iInfection. Br J Haematol, 2020; 190: 3.

Downloads

Submitted

2022-10-07

Accepted

2022-11-30

Published

2023-01-19

How to Cite

[1]
Sari, A.F., Rikarni, R. and Desywar, D. 2023. Correlation of Mean Platelet Volume with D-dimer in Patients with COVID-2019. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 29, 1 (Jan. 2023), 1–5. DOI:https://doi.org/10.24293/ijcpml.v29i1.2030.

Issue

Section

Articles